Bayer (0P6S) Gets a Hold from Kepler Capital
Kepler Capital analyst Christian Faitz maintained a Hold rating on Bayer (0P6S – Research Report) on January 21 and set a price target of ...
PharmaTimes1d
Mike Knowland
UK constumer healthcare association PAGB has appointed Bayer’s Mike Knowland as its new President. Knowland, who was ...
J.P. Morgan Sticks to Their Hold Rating for Bayer (0P6S)
In a report released today, Richard Vosser from J.P. Morgan maintained a Hold rating on Bayer (0P6S – Research Report), with a price target of ...
Thailand Business News2d
India Remains a Magnet for Pharmaceutical Investments Despite Regulatory Challenges
Bayer's expanded therapies and strategic collaborations in India aim to drive pharmaceutical growth amidst regulatory challenges and pricing pressures.
Bayer AG Enterprise Digital Transformation Strategy Report 2024: Accelerators, Incubators, and Innovation Programs
The "Enterprise Tech Ecosystem Series: Bayer AG 2024" report has been added to ResearchAndMarkets.com's offering. The report provides insights into Bayer AG's tech activities, including its digital ...
TMCnet2d
Leaps by Bayer Announces One of the Largest Global Surveys of Society's Attitudes Toward Breakthrough Technologies
As leaders gather for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm of Bayer, and Boston Consulting Group (BCG) announced the launch of one of the ...
Multiple Sclerosis News Today6d
Bayer’s MRI contrast agent effective with 60% less gadolinium: Data
Gadoquatrane, a contrast agent Bayer is developing for use in MRI scans, like those done in MS, uses 60% less gadolinium and ...
MM&M6d
How Bayer cracked the retail media code
The pharmaceutical company’s latest partnership with Incremental and Skai drove a 32% boost in iROI, delivering nearly a third more sales per ad dollar.